Extensive lymph-node dissection in gastric cancer: is it of therapeutic value?
- 31 July 1996
- journal article
- editorial
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 22 (4) , 247-252
- https://doi.org/10.1016/s0305-7372(96)90018-3
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trialThe Lancet, 1996
- Guest editorial: “EXTENDED” lymph node dissections for gastric cancer—Is more better?Journal of Surgical Oncology, 1996
- Prognostic relevance of systemic lymph node dissection in gastric carcinomaBritish Journal of Surgery, 1995
- Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patientsThe Lancet, 1995
- New method to evaluate the therapeutic value of lymph node dissection for gastric cancerBritish Journal of Surgery, 1995
- A Prospective Randomized Trial Comparing R1 Subtotal Gastrectomy with R3 Total Gastrectomy for Antral CancerAnnals of Surgery, 1994
- Prognostic relevance of systematic lymph node dissection in gastric carcinomaBritish Journal of Surgery, 1993
- A critical evaluation of effectivity of extended lymphadenectomy in patients with carcinoma of the stomachZeitschrift für Krebsforschung und Klinische Onkologie, 1990
- Randomized comparison of R1 and R2 gastrectomy for gastric carcinomaBritish Journal of Surgery, 1988
- The general rules for the gastric cancer study in surgery and pathologySurgery Today, 1981